17:22 · 16 June 2026

Nasdaq near record high 🔼 Is a double top forming?

The decline in oil prices and the prospect of the Strait of Hormuz reopening have triggered a surge of optimism on Wall Street, further supported by SpaceX’s IPO and solid macroeconomic data from the US economy. The recent sell-off in AI-related stocks such as Oracle and Broadcom has largely been erased, as investors rushed back into the market, pushing the index above the 30,000-point mark once again. The key question now is whether the bulls have enough momentum to break through to new record highs.

From a technical analysis perspective, the uptrend remains firmly intact. However, the pace of the rally over the past few sessions raises some questions. Since 11 June, the index has gained nearly 2,200 points, a move that appears unusually strong by historical standards. At the same time, both the RSI and MACD indicators on the daily chart have been trending lower since May, creating a bearish divergence with price action.

While it is impossible to predict whether the US100 will surpass its early-June record, the index is currently only around 300 points away from that level, suggesting that market sentiment may be approaching euphoric territory. Ahead of the US market open, futures are trading slightly lower on an intraday basis.

Source: xStation5

17 June 2026, 14:26

European auto industry under pressure - BMW at its lowest since 2020

17 June 2026, 13:33

Chart of the Day: A New Era at the Fed and the Hawkish Shadow of the ECB. EURUSD at a Turning Point

17 June 2026, 09:53

Morning Wrap: Emotions Subside After the Truce. The Fed Takes Center Stage in the Markets

16 June 2026, 21:53

Daily Summary - Oil Nearly Erases War Gains as Wall Street Pulls Back Ahead of Fed Decision (16.06.2026)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.